Explore the detailed process of how generic drugs are manufactured, from reverse engineering brand names to the ANDA approval pathway and bioequivalence testing.
ACE inhibitors and ARBs are the cornerstone of treatment for diabetic nephropathy, reducing proteinuria and slowing kidney damage. Maximal dosing is key-low doses offer little protection. Learn when to use them, when to avoid combinations, and how to handle creatinine changes.
TNF inhibitors have transformed ankylosing spondylitis treatment by targeting the root cause of spine inflammation. Learn how these biologics reduce pain, improve mobility, and slow disease progression - and which patients benefit most.
Authorized generics are identical to brand-name drugs but cost less because they skip marketing costs and trigger immediate price competition. Learn how they work, why they’re cheaper, and how to get them.
A deep dive into imipramine's discovery, FDA approval, clinical impact, and why it still matters in modern psychiatry.
Generic drugs save billions and work just as well as brand-name versions. Learn what the FDA requires for therapeutic equivalence, why labels look different, and when to watch for subtle changes.